Synthesis, Potency, and in Vivo Evaluation of 2-Piperazin-1-ylquinoline Analogues as Dual Serotonin Reuptake Inhibitors and Serotonin 5-HT1AReceptor Antagonists
Authors:
- 21 July 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (15) , 4955-4959
Abstract
On the basis of the previously reported clinical candidate, SSA-426 (1), a series of related 2-piperazin-1-ylquinoline derivatives 3−16 were synthesized and evaluated as dual-acting serotonin (5-HT) reuptake inhibitors and 5-HT1A receptor antagonists. In particular, compound 7 exhibits potent functional activities at both the 5-HT transporter and 5-HT1A receptor, good selectivity over the α1-adrenergic and dopaminergic receptors, acceptable pharmacokinetic properties, and a favorable in vivo profile.Keywords
This publication has 18 references indexed in Scilit:
- First Scale-Up: Problems and Resolutions on the Synthesis of WAY-253752, a Novel, Dual-Acting SSRI/5HT1A AntagonistOrganic Process Research & Development, 2007
- 3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Pindolol Augmentation of Antidepressant ResponseCurrent Drug Targets, 2006
- Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4Bioorganic & Medicinal Chemistry Letters, 2004
- Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortexJournal of Psychopharmacology, 2002
- Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometerJournal of Pharmacological and Toxicological Methods, 1998
- Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake InhibitorsArchives of General Psychiatry, 1994
- [3H]Paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: Effect of administration of various antidepressant treatmentsNeuropharmacology, 1993
- DU 24565, a quipazine derivative, a potent selective serotonin uptake inhibitorEuropean Journal of Pharmacology, 1981
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973